Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2017 2
2018 1
2019 1
2021 1
2022 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean sumiyoshi morikawa (14 results)?
Decreased circulating branched-chain amino acids are associated with development of Alzheimer's disease in elderly individuals with mild cognitive impairment.
Ikeuchi T, Kanda M, Kitamura H, Morikawa F, Toru S, Nishimura C, Kasuga K, Tokutake T, Takahashi T, Kuroha Y, Miyazawa N, Tanaka S, Utsumi K, Ono K, Yano S, Hamano T, Naruse S, Yajima R, Kawashima N, Kaneko C, Tachibana H, Yano Y, Kato Y, Toue S, Jinzu H, Kitamura A, Yokoyama Y, Kaneko E, Yamakado M, Nagao K. Ikeuchi T, et al. Among authors: morikawa f. Front Nutr. 2022 Dec 14;9:1040476. doi: 10.3389/fnut.2022.1040476. eCollection 2022. Front Nutr. 2022. PMID: 36590218 Free PMC article.
Real-world effectiveness of antipsychotic treatments in 1011 acutely hospitalized patients with schizophrenia: A one-year follow-up study.
Hatta K, Katayama S, Ishizuka T, Sudo Y, Nakamura M, Hasegawa H, Imai A, Morikawa F, Shimada T, Misawa F, Ozaki S, Fujita K, Watanabe H, Nakamura H, Sugiyama N; JAST study group. Hatta K, et al. Among authors: morikawa f. Asian J Psychiatr. 2022 Jan;67:102917. doi: 10.1016/j.ajp.2021.102917. Epub 2021 Nov 6. Asian J Psychiatr. 2022. PMID: 34875558 Free article.
Development of a Novel Nutrition-Related Multivariate Biomarker for Mild Cognitive Impairment Based on the Plasma Free Amino Acid Profile.
Ikeuchi T, Yano Y, Sato W, Morikawa F, Toru S, Nishimura C, Miyazawa N, Kuroha Y, Koike R, Tanaka S, Utsumi K, Kasuga K, Tokutake T, Ono K, Yano S, Naruse S, Yajima R, Hamano T, Yokoyama Y, Kitamura A, Kaneko E, Yamakado M, Nagao K. Ikeuchi T, et al. Among authors: morikawa f. Nutrients. 2022 Feb 1;14(3):637. doi: 10.3390/nu14030637. Nutrients. 2022. PMID: 35276996 Free PMC article.
A prospective naturalistic multicenter study on choice of parenteral medication in psychiatric emergency settings in Japan.
Hatta K, Katayama S, Morikawa F, Imai A, Fujita K, Fujita A, Ishizuka T, Abe T, Sudo Y, Hashimoto K, Usui C, Nakamura H, Yamanouchi Y, Hirata T; JAST study group. Hatta K, et al. Among authors: morikawa f. Neuropsychopharmacol Rep. 2018 Sep;38(3):117-123. doi: 10.1002/npr2.12015. Epub 2018 May 24. Neuropsychopharmacol Rep. 2018. PMID: 30175524 Free PMC article.
Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia.
Hatta K, Hasegawa H, Imai A, Sudo Y, Morikawa F, Katayama S, Watanabe H, Ishizuka T, Nakamura M, Misawa F, Fujita K, Ozaki S, Umeda K, Nakamura H, Sawa Y, Sugiyama N; JAST study group. Hatta K, et al. Among authors: morikawa f. Asian J Psychiatr. 2019 Feb;40:82-87. doi: 10.1016/j.ajp.2019.02.005. Epub 2019 Feb 8. Asian J Psychiatr. 2019. PMID: 30772732
The possibility that requiring high-dose olanzapine cannot be explained by pharmacokinetics in the treatment of acute-phase schizophrenia.
Hatta K, Takebayashi H, Sudo Y, Katayama S, Kasuya M, Shirai Y, Morikawa F, Nakase R, Nakamura M, Ito S, Kuga H, Nakamura M, Ohnuma T, Usui C, Nakamura H, Hirata T, Sawa Y; JAST study group. Hatta K, et al. Among authors: morikawa f. Psychiatry Res. 2013 Dec 15;210(2):396-401. doi: 10.1016/j.psychres.2013.07.005. Epub 2013 Aug 4. Psychiatry Res. 2013. PMID: 23919898 Clinical Trial.
Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
Hatta K, Otachi T, Fujita K, Morikawa F, Ito S, Tomiyama H, Abe T, Sudo Y, Takebayashi H, Yamashita T, Katayama S, Nakase R, Shirai Y, Usui C, Nakamura H, Ito H, Hirata T, Sawa Y; JAST study group. Hatta K, et al. Among authors: morikawa f. Schizophr Res. 2014 Sep;158(1-3):213-22. doi: 10.1016/j.schres.2014.07.015. Epub 2014 Jul 31. Schizophr Res. 2014. PMID: 25086659 Free article. Clinical Trial.
11 results